Advertisement

Inhibitors of the Precipitation of Stone-Forming Urinary Constituents: are the Established Inhibitors Effective in Preventing Stone Formation and Growth or is A Moss-Covered Stone Inevitable?

  • J. D. Sallis
Conference paper

Abstract

There is no concensus on the controversy concerning the nature, function or effectiveness of either natural or synthetic inhibitors in relation to urinary stone formation. Since the pioneering work of the Fleisch group in recognizinq the inhibitory potential of the urinary constituent, pyrophosphate1, the search has been escalated to find a constituent which might effectively control the development of a stone. Today, a number of natural compounds have been presented as possible candidates. Simultaneously, knowledge is advancing on inhibitor mechanisms prompting the development of synthetic compounds as hopeful therapeutic agents.

Keywords

Calcium Phosphate Calcium Oxalate Amorphous Calcium Phosphate Calcium Oxalate Crystal Urinary GAGs 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    H. Fleisch and S. Bisaz, Am. J. Physiol. 203:671 (1962)PubMedGoogle Scholar
  2. 2.
    S. Bisaz, R. Felix, W. F. Neuman, and H. Fleisch, Min. Electr. Metab. 1:74 (1978).Google Scholar
  3. 3.
    H. Fleisch, S. Bisaz, and A. D. Care, Lancet 1:1065 (1964).PubMedCrossRefGoogle Scholar
  4. 4.
    A. Woefel, R. A. Kaplan, and C. Y. C. Pak, Metabolism 26:201 (1977).CrossRefGoogle Scholar
  5. 5.
    P. C. Hallson, G. A. Rose, and S. Sulaiman, Clin. Sci. 62:17 (1982).PubMedGoogle Scholar
  6. 6.
    B. B. Tomazic and G. H. Nancollas, J. Urol. 128:205 (1982).PubMedGoogle Scholar
  7. 7.
    H. G. Rushton, M. Spector, A. L. Rodgers, M. Hughson, and C. E. Magura, Invest. Urol. 19:52 (1981).PubMedGoogle Scholar
  8. 8.
    C. D. Fetner, D. E. Barilla, J. Townsend, and C. Y. C. Pak, J. Urol. 120:399 (1978).PubMedGoogle Scholar
  9. 9.
    H. G. Tiselius, C. Ahlstrand, and L. Larsson, Urol. Res. 8:197 (1980).PubMedCrossRefGoogle Scholar
  10. 10.
    P. O. Schwille, D. Scholz, M. Paulus, W. Engelhardt, and Sigel, Invest. Urol. 16:457 (1979).PubMedGoogle Scholar
  11. 11.
    J. L. Meyer and W. C. Thomas, J. Urol 128:1376 (1982).PubMedGoogle Scholar
  12. 12.
    H. Fleisch, Scand J. Urol. Nephrol. (Suppl) 53:53 (1980).Google Scholar
  13. 13.
    R. L. Ryall, R. M. Harnett, and V. R. Marshall, Clin Chim Acta, 112:349 (1981).PubMedCrossRefGoogle Scholar
  14. 14.
    W. G. Robertson, M. Peacock, and B. E. C. Nordin, Clin Chim. Acta 43:31 (1973).CrossRefGoogle Scholar
  15. 15.
    J. D. Sallis and M. F. Lumley, Invest. Urol. 16:296 (1979).PubMedGoogle Scholar
  16. 16.
    Y. Nakagawa, H. C. Margolis, S. Yokoyama, F. J. Kezdy, E. T. Kaiser, and F. L. Coe, J. Biol. Chem 256:3936 (1981).PubMedGoogle Scholar
  17. 17.
    T. Kitamura, J. E. Zerwekh, and C. Y, C. Pak, Kidney Int. 21:379 (1982).PubMedCrossRefGoogle Scholar
  18. 18.
    P. C. Hallson and G. A. Rose, Lancet i:1000 (1979).CrossRefGoogle Scholar
  19. 19.
    W. O. Foye, H. S. Hong, C. M. Kim, and E. L. Prien, Invest. Urol. 14:33 (1976).PubMedGoogle Scholar
  20. 20.
    H. Itatani, H. Itoh, T. Yoshioka, M. Namiki, T. Koide, A. Okuyama, and T. Sonoda, Invest. Urol. 19:119 (1981).PubMedGoogle Scholar
  21. 21.
    K. A. Edyvane, R. L. Ryall, and V. R. Marshall, in “Urinary Stone”, R. Ryall, J. G. Brockis, V. Marshall, and B. Finlayson, eds., Churchill Livingstone, Melbourne (1984).Google Scholar
  22. 22.
    J. E. Zerwekh, K. Holt, and C. Y. C. Pak, Kidney Int. 23:838 (1933).CrossRefGoogle Scholar
  23. 23.
    H. Fleisch, Met. Bone Dis. Rel. Res. 4&5:279 (1981).CrossRefGoogle Scholar
  24. 24.
    R. R. Recker and P. D. Saville, Tox. Appl. Pharm. 24:580 (1973).CrossRefGoogle Scholar
  25. 25.
    H. G. Bone, J. E. Werwekh, F. Britton, and C. Y. C. Pak, J. Urol. 121:568 (1979).PubMedGoogle Scholar
  26. 26.
    H. Shimoda, G. Adamek, R. Felix, H. Fleisch, R. Schenk, and P. Hagan, Calc. Tiss. Int. 35:87 (1983).CrossRefGoogle Scholar
  27. 27.
    G. Williams and J. D. Sallis, Anal. Biochem. 102:365 (1980).PubMedCrossRefGoogle Scholar
  28. 28.
    W. P. Tew, C. Mahle, and A. L. Lehninger, Biochemistry 19:1983 (1980).PubMedCrossRefGoogle Scholar
  29. 29.
    G. Williams and J. D. Sallis, in “Urolithiasis, Clinical and Basic Research, L. H. Smith, W. G. Robertson, and B. Finlayson, eds., Plenum, New York (1981).Google Scholar
  30. 30.
    G. Williams and J. D. Sallis, Biochem. J. 184:181 (1979).PubMedGoogle Scholar
  31. 31.
    G. Williams and J. D. Sallis, Calc. Tiss. Int. 34:169 (1983).CrossRefGoogle Scholar
  32. 32.
    M. R. Brown and J. D. Sallis, in: “Urolithiasis and Related Clinical Research”, P. O. Schwille, W. G. Robertson, L. H. Smith, W. Vahlensieck, eds., Plenum, London (1985).Google Scholar
  33. 33.
    R. Shankar, S. Crowden, and J. D. Sallis, Atherosclerosis (1984) (in press).Google Scholar
  34. 34.
    M. R. Brown and J. D. Sallis, Anal. Biochem. 132:115 (1983).PubMedCrossRefGoogle Scholar
  35. 35.
    W. Berg, A. Hesse, K. Hensel, G. Unger, U. Hartmann, and H. J. Schneider, Urologie, 15:188 (1976).Google Scholar
  36. 36.
    H. J. Schneider, G. Unger, D. Rossle, C. Bothor, W. Berg, and G. Ernst, Z. Urol. Nephrol. 72:237 (1979).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • J. D. Sallis
    • 1
  1. 1.Dept. of BiochemistryUniversity of TasmaniaHobartAustralia

Personalised recommendations